Aquestive Therapeutics Inc (AQST)
R&D Expense Growth
-5.76%
Quarterly · Period ending:
AQST R&D Expense Growth
Latest reported-5.76%period ending
Latest reported-5.76%period ending
AQST Quarterly R&D Growth (QoQ) (0.00% → -5.76%)
Latest values, visible window
High-resolution chart · PNG
AQST r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -5.7564% | |
| 31.5394% | |
| -29.4481% | |
| 10.3532% | |
| -23.4285% | |
| 9.0299% | |
| -6.6806% | |
| 26.5978% | |
| -29.8382% | |
| 105.4017% | |
| -9.637% | |
| -7.9758% | |
| -2.0863% | |
| -17.0874% | |
| 32.3639% | |
| -37.8222% | |
| 8.9043% | |
| 8.4773% | |
| -6.898% | |
| 10.8869% | |
| 16.4799% | |
| -17.3107% | |
| -39.0496% | |
| 88.7185% | |
| -11.6445% | |
| 42.4272% | |
| -39.6208% | |
| -37.8849% | |
| 89.426% | |
| -24.2829% | |
| 25.3419% | |
| -43.2825% | |
| 63.1096% | |
| -21.8466% | |
| 10.3272% | |
| 17.5109% | |
| -9.4703% | |
| 0% |